Clinical Trial Update: Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate ursodeoxycholic acid for preventing relapsing complications after gallstone-related acute pancreatitis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Hospital General Universitario de Alicante | Conditions: Acute Pancreatitis Due to Gallstones | Phase 3 | Status: RECRUITING